ResMed (RMD) Tops Q4 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.99 --0%
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.95, $0.06 better than the analyst estimate of $2.89. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.47 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Starts IQM Quantum Computers (IQMX) at Buy, PT $20
- PB Fintech Limited (POLICYBZ:IN) PT Raised to INR1,970 at BofA Securities
- Credo Tech (CRDO) PT Lowered to $245 at Mizuho
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
